About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
CPOE systems should be smarter. Local customization of individual medication-related alerts is a good place to start.
Karl A. Matuszewski, MS, PharmD
The FDA has delivered its highly anticipated guidelines for industry on how to
respond to unsolicited requests (via social media platforms) for off-label information about prescription drugs and medical devices. The reviews have been mixed.
Cost Analysis Before and After Implementation of a Computerized Physician Order Entry Order Form for Enoxaparin
The authors set out to determine whether a computerized physician order entry (CPOE) order form for enoxaparin would result in a lower cost of drug therapy per day if patients were switched to once-daily administration. Use of the CPOE enoxaparin order form did not reduce the daily cost of therapy, although cost savings did result when the hospital’s protocol was followed.
Rebecca S. Pettit, PharmD, MBA, BCPS; Christopher R. Zimmerman, PharmD, BCPS; Cesar Alaniz, PharmD; and Michael P. Dorsch, PharmD, MS, BCPS
34th Annual San Antonio Breast Cancer Symposium and 53rd American Society of Hematology Annual Meeting and Exposition
Acceptance or Rejection by Stakeholders Will Influence Congress
Some say that the FDA’s proposed REMS opioids initiative does not go far enough to protect patients.
Misprogramming pump levels of patient-controlled analgesia can lead to dosing errors.
Matthew Grissinger, RPh, FASCP
FDA approvals, drug indications, and updates
Advate to prevent bleeding; Edarbi and Edarbyclor for hypertension; and Anturol gel for overactive bladder
Marvin M. Goldenberg, PhD, RPh, MS
Arcapta Neohaler for chronic obstructive pulmonary disease
Rachel M. Slaton, PharmD, BCPS; and Danielle L. Cruthirds, PhD